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ABSTRACT
Rearrangements of the genome can be detected by
microarray methods and massively parallel
sequencing, which identify copy-number alterations
and breakpoint junctions, but these techniques are
poorly suited to reconstructing the long-range
organization of rearranged chromosomes, for ex-
ample, to distinguish between translocations and
insertions. The single-DNA-molecule technique
HAPPY mapping is a method for mapping normal
genomes that should be able to analyse genome re-
arrangements, i.e. deviations from a known genome
map, to assemble rearrangements into a long-range
map. We applied HAPPY mapping to cancer cell
lines to show that it could identify rearrangement
of genomic segments, even in the presence of
normal copies of the genome. We could distinguish
a simple interstitial deletion from a copy-number
loss at an inversion junction, and detect a known
translocation. We could determine whether junc-
tions detected by sequencing were on the same
chromosome, by measuring their linkage to each
other, and hence map the rearrangement. Finally,
we mapped an uncharacterized reciprocal trans-
location in the T-47D breast cancer cell line
to about 2kb and hence cloned the translocation
junctions. We conclude that HAPPY mapping is a
versatile tool for determining the structure of
rearrangements in the human genome.
INTRODUCTION
Genome rearrangements, such as chromosome transloca-
tions and tandem duplications, play a major role in
inherited genetic disease and cancer (1,2). In particular,
it has emerged that chromosome translocations and
other genome rearrangements play an important role in
the common cancers, such as prostate and lung cancer,
just as they do in leukaemias and sarcomas (2,3), and
duplications and deletions are at least as important
as single-nucleotide polymorphisms in constitutional
disease (1).
Full analysis of genome rearrangements requires map
information, i.e. information about distances between par-
ticular sequences (markers) and how they are linked
together, as illustrated in Figure 1. Few of the tools
available for genomics do this. For example, array-
comparative genomic hybridization (CGH) can identify
unbalanced breakpoints as steps in the copy-number
proﬁle, but does not give information about how the
breaks are joined together. Even the new techniques
based on sequencing, such as paired-end-read strategies
(4–6), identify breakpoint junctions but do not show
how these junctions are joined together (Figure 1D–G).
In particular, paired-end-read sequencing identiﬁes new
junctions created by genome rearrangement, but cannot
tell whether these junctions are on the same rearranged
chromosome or not. More generally, most available gen-
omic tools provide only local information, which cannot
readily be used to determine large-scale organisation.
HAPPY mapping is a genome mapping technique that
measures linkage, and hence the physical distance,
between markers, over a wide range of distances—from
<1kb to >200kb (7–9). It was used, for example, in the
construction of the framework map of human chromo-
some 14 (10). HAPPY mapping exploits the fact that
when the genome is broken into pieces, neighbouring se-
quences will tend to remain together more often than
distant sequences (Figure 2). A fragmented genome is
diluted until samples contain a fraction of a haploid
genome. These samples are then assayed for the presence
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together will be present in the same samples, while distant
marker sequences will show an unrelated pattern of distri-
bution amongst samples (Figure 2) (11). Thus, HAPPY
mapping is conceptually analogous to mapping by inher-
itance in families (meiotic mapping) and radiation-hybrid
mapping, but works by examining single DNA molecules.
HAPPY mapping has until now been used to map
normal genomes [e.g. (8,10)], but it should also be applic-
able to detecting and analysing rearrangements of a
known genome, by looking for changes in expected link-
age. It could complement genome-wide methods by
determining the physical relationship between rearranged
sections of the genome. A chromosome translocation, for
example, will create new linkage between the newly
juxtaposed sequences, and weaken linkage between the
sequences separated by breakage. This would enable
HAPPY mapping to distinguish between situations such
as those shown in Figure 1. It should also detect balanced
rearrangements, such as inversions, which are not detected
by array-CGH.
We demonstrate here that HAPPY mapping works well
when applied to various types of rearrangement of the
human genome, by applying it to cancer cell lines. In par-
ticular, we show that it is sufﬁciently sensitive to map
rearrangements in the presence of normal as well as
rearranged copies of the genome.
METHODS
HAPPY mapping method
The HAPPY mapping method (7,11) is outlined in Figure 2.
DNA is fragmented to a desired size range, highly diluted
and samples taken so that approximately half the samples
are positive for any given marker, corresponding to about
0.7 haploid genomes per sample (due to the Poisson dis-
tribution of molecules). Typically 88 samples are taken
(a 96-well plate with eight wells as negative controls),
and then the presence or absence of all the marker
sequences is assayed in each of the diluted samples.
In the current implementation of HAPPY mapping,
polymerase chain reaction (PCR) markers are used.
PCR is in two stages: ﬁrst, primers for all markers are
pooled and used in a multiplexed PCR, amplifying all
the target sequences simultaneously in each of the 88
diluted samples. The ampliﬁcation product from each
sample is then diluted and divided into a number of rep-
licate 96-well or 384-well plates, and individual markers
speciﬁcally ampliﬁed using semi-nested primers, i.e. one of
the primers used in the multiplex PCR, with a new nested
primer. These second-round PCR products are scored for
presence or absence of the marker.
As illustrated in the ﬁrst example below, the nearer that
two markers are in the genome, the more similar the dis-
tribution of positive PCRs over the samples will be.
In addition to providing mapping information, the data
provide copy-number information: the number of positive
samples for a given marker will reﬂect the relative copy
number of the marker in the genome (Figure 2E and F).
This method of measuring copy number changes has been
dubbed Molecular Copy-number Counting (MCC) (9,12).
Data analysis
The linkage calculations are essentially those used in
genetic linkage mapping and radiation hybrid mapping.
Brieﬂy, for any two markers, the software calculates the
probability (P) of seeing the experimentally observed
degree of co-segregation (i.e. the observed proportion of
concordant typing results) when the assumed frequency of
physical breaks between the two markers ( ) is varied from
0 (markers are adjacent, never broken apart) to 1 (markers
are inﬁnitely far apart, and hence always separated by
DNA breaks). It then divides the maximum value of P
by the value of P at   = 1, and takes the logarithm
(base 10) of the result. This is the log of odds (LOD)
score for linkage between the two markers. Linkage
A
B
C
E
F
G
D
Figure 1. Linkage information is needed to determine the structure of
some genome rearrangements. (A–C) Two rearrangements that cannot
be distinguished by array-CGH. (A) Array-CGH proﬁle that would be
obtained for the black chromosome from either (B) or (C). (B) A small
deletion in the black chromosome; (C) a reciprocal translocation has
resulted in net loss of a small section of the black chromosome at the
translocation breakpoints. (D–G) Two rearrangements that cannot be
distinguished either by array-CGH or by ﬁnding breakpoint junctions
by large-scale sequencing (5,6), but could be distinguished by HAPPY
mapping, provided the breakpoints are within 1Mb of each other. (D)
Array-CGH data for the black chromosome obtained from either (F)
or (G); (E) junction sequences obtained from either (F) or (G); (F) a
piece of the black chromosome is inserted between pieces of the grey
and white chromosomes; while in (G), there are two separate transloca-
tions of the black chromosome with respectively the grey and white
chromosomes, both including the region between the dotted lines. (The
grey and white ‘chromosomes’ could also represent other parts of the
black chromosome, as in an inversion, for example).
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using custom software (Dear,P.H., unpublished data).
The genomic copy number at each marker was
calculated from the proportion (P) of the 88 samples
found to be positive for the marker sequence using the
Poisson equation. The average number of copies of that
marker sequence in each sample (copies per sample, or
CPA), is
CPA ¼ lnð1   PÞ
CPA is proportional to the number of copies of a given
marker sequence per genome.
DNA template preparation
Cell culture has been described (13). DNA was prepared
by casting cells in agarose in capillaries, extruding the
‘strings’ of agarose and repeated extraction with 1% Li
dodecyl sulphate, 10mM Tris buffer, 1mM ethylenedia-
minetetraacetic acid (EDTA), pH 8.0 (10). DNA dilutions
were generally made by cutting deﬁned lengths from the
‘strings’, melting them in 0.5  PCR buffer in high-
performance liquid chromatography (HPLC) grade
water, at 69 C for 5min, and taking samples directly
without further dilution or shearing. DNA was typically
diluted to  0.7 haploid genomes of DNA per 5-ml sample
(about 0.4pg/ml for a diploid genome). To adjust this and
allow for aneuploidy of cancer cells, various DNA dilu-
tions were tested in a preliminary PCR. Five-microlitre
samples were then dispensed into 88 wells of 96-well
microtitre plates, with eight wells as negative controls,
without the use of a repeat pipettor to minimize shearing
of the DNA, and stored at  80 C under mineral oil. Such
dilutions typically show an average DNA fragment size
(deduced from PCR results as in Figure 3A) of
100–200kb, and proved suitable for the experiments
reported here. Alternatively, up to 0.5–1-Mb fragments
can be preserved by cutting them directly from a pulsed-
ﬁeld gel electrophoresis (10); this method was used for
Figure 1A–C, taking nominally 500-kb fragments,
because the data were taken from a larger mapping
exercise. Smaller DNA could also be used for small-scale
mapping, by increasing the shearing. Dilution, optional
preampliﬁcation and ﬁrst-round PCRs were set up in a
‘clean room’ to minimize risk of contamination, which
in practice is not a signiﬁcant problem, as conﬁrmed by
Figure 2. Combined HAPPY mapping and molecular copy-number counting gives positional information and copy number. (A) The circles repre-
sent marker sequences on chromosomes in a normal cell. (B) An unbalanced translocation leaves one copy of each normal chromosome and one
copy of a hybrid chromosome (grey). (C) DNA is prepared and broken at random; each fragment is large enough to span several markers. (D)
Fragmented DNA is dispensed into samples (typically 88), each containing about half a genome’s worth of fragments. (E) Each sample is scored,
usually by multiplexed PCR, for the presence (ticks) of each marker. The red and yellow markers always occur together (co-segregate), since they
remain adjacent on all chromosomes; the red and green markers cosegregate often (four of the samples) but not always (four samples contain the red
marker without the green), since they remain adjacent on the normal chromosome but not the hybrid chromosome; likewise, the red and black
markers, which are brought together on the hybrid chromosome, occur together in about half of the samples. Other pairs of markers that are never
adjacent (e.g. black and green; blue and red) occur together only occasionally, by chance. (F) The number of samples that score positive for any
given marker also reﬂects the relative number of copies in the genome; in this idealized example, the green and blue markers are present at only half
the copy-number of the others. This way of measuring copy number has been described previously as molecular copy-number counting (12).
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copy-number data obtained. The number of samples could
also be varied, but 88 proved a good compromise:
increasing, say to 2 X 88 increases statistical power, but
marker results and resolution are also limited by the per-
formance of individual primers sets and their spacing, so it
is usually better to double the number of markers rather
than the number of samples per marker. However, where
linkage is limited by the size of DNA fragments, the extra
statistical power of using 2 X 88 samples is valuable: an
example is shown in Figure 6.
Preampliﬁcation
Before marker PCR, an optional preampliﬁcation can be
performed, by random primer extension (PEP-PCR) (14).
This provides a number of plates with identical template,
so that additional marker sets can be tested sequentially
on the same samples (14). This was used in the HCC1187
translocation experiment (Figure 5). PEP-PCR was
carried out in a total volume of 7ml containing 10mMo f
degenerate 15-mer PCR primer, 1 PCR buffer II
(Applied Biosystems, City California, USA), 2mM
MgCl2, 200mM each dNTP and 0.1U/ml Amplitaq DNA
polymerase (Applied Biosystems). Thermocycling condi-
tions were 93 C for 5min, followed by 50 cycles of 30s
at 94 C, 2min at 37 C, a temperature ramp of 0.1 Cs
 1
up to 55 C, 4min at 55 C. The PEP-PCR was then diluted
with 200ml of water and aliquotted 5ml per well into rep-
licate 96-well plates.
Two-stage PCR
PCR was semi-nested, i.e. primer sets consisted of three
primers: the ﬁrst PCR used a forward-external and reverse
primer, the second PCR used a forward-internal and the
same reverse primer. Internal amplimer length was de-
signed to be 60–150bp, and the position of the external
primer no more than 150bp upstream of forward-internal
primer. Primers (Supplementary Table S1) were generally
designed automatically using custom software (Dear,P.H.,
unpublished data) against the repeat-masked human ref-
erence genome sequence NCBI Build 36. Typically, primer
length was 20–23bp; melting temperature (Tm) 52–60 C
[based on Tm =2  (A+T)+4 (G+C)]; with at least
two guanine or cytosine bases at the 30 end and at least
one at the 50 end; and no runs of 4 or more of the same
base allowed. Some primers were designed manually using
Primer3 (http://frodo.wi.mit.edu/), without repeat masking.
Primers were then tested by in silico PCR for unique-
ness (http://genome.ucsc.edu/cgi-bin/hgPcr?command=
start). Primers were supplied by Euroﬁns MWG Operon
(Ebersberg, Germany) and Sigma-Aldrich (Poole, UK). A
small proportion of newly designed primer sets will fail
(11), but the distinction between a failed and deleted
marker can be made by testing the markers on normal
DNA.
The ﬁrst of the two PCRs was a multiplex PCR, using a
pool of the forward-external and reverse primers for all
markers. [Previous work shows that this is robust to over
1000 markers (15).] The ﬁrst PCR products were diluted
and replicated into multiple 96-well plates, each used for a
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Figure 3. Distinguishing between simple deletion and loss at a re-
arrangement junction. (A, B) HAPPY mapping indicates that copy
number loss at 36.5Mb on chromosome 8 in T-47D is an interstitial
deletion; (A) part of raw data. Rows are PCR markers, vertical scale is
genome position. Columns are 20 (of 88) diluted DNA samples.
Horizontal lines are PCR markers and the individual dashes represent
PCR results; positive hits are joined by vertical black bars, representing
the presence of DNA. The possible deletion is shaded. Evidence that
this is a simple interstitial deletion comes from the concordance of
markers that ﬂank the copy number loss, i.e. markers are positive on
both sides or negative on both sides. This is expressed (B) as linkage
between markers, calculated as the log of odds (LOD) that the markers
are linked, using all 88 samples. Horizontal lines represent markers,
loops (arcs) represent linkage between them: the stronger the linkage,
the further the loop extends to the right. For clarity, only linkage LOD
> 7 is shown, and linkage to the markers within the deletion is omitted.
(C) Copy-number loss at 38.2Mb on chromosome 8. Linkage LOD > 5
is shown. In contrast to (A, B), this is loss at an inversion junction, and
there is no linkage of this strength across the copy number loss, even
though, because DNA fragments were large, linkage over ﬂanking se-
quences extends >100kb.
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semi-nested PCRs were performed for each individual
marker, using the forward-internal and reverse primers
for one marker.
PCR was otherwise conventional. Phase 1 reactions
were in 10ml containing 0.15mM of each oligo, Gold
PCR buffer (Applied Biosystems), 2mM MgCl2, 200mM
each dNTP and 0.1U/ml Taq Gold DNA polymerase
(Applied Biosystems). Thermocycling conditions were a
hot start at 93 C for 9min, followed by 28 cycles of 20s
at 94 C, 30s at 50 C and 1min at 72 C. Products were
diluted to 1000ml with water and 5ml replicated into fresh
microtitre plates for Phase 2 PCR.
The Phase 2 PCRs used the forward-internal and
reverse primer for one marker on each 88-well set of
diluted phase 1 products. For convenience, the transfers
of template were done robotically into 384-well microtitre
plates, each plate containing the reactions for four
markers. Reaction conditions for the Phase 2 PCR were
1  PCR Gold buffer, 1.5mM MgCl2, 200mM each
dNTP, and 1  EvaGreen dye (Biotium Inc, Hayward,
CA, USA), with 1mM of the relevant forward-internal
and reverse primers, and thermocycling at 93 C for
9min, followed by 33 cycles of 20se 94 C, 30s 54 C and
1min 72 C.
Results were scored either by electrophoresis on poly-
acrylamide gels or by melting-curve analysis on a real-time
PCR thermocycler. For electrophoresis, precast 108-well
horizontal 6% polyacrylamide gels (MIRAGE gels,
Genetix, Hampshire, UK; or made in house) were run
for 10min at 10V/cm. Melting-curve analysis was in an
ABI 7900HT (Applied Biosystems) with the manufactur-
er’s SDS software and using the EvaGreen dye included in
the second PCR reactions.
RESULTS
A copy-number loss that was a simple interstitial deletion
We ﬁrst tested HAPPY mapping’s ability to distinguish
between different situations that result in local loss of
copy number: loss can result from a simple interstitial
deletion, or from loss of sequence at the breakpoints of
a rearrangement such as a translocation or inversion
(Figure 1A–C). HAPPY mapping measures linkage be-
tween markers and a simple interstitial deletion will pre-
serve or even increase the linkage between the markers
that ﬂank it, whereas pieces of chromosome that are
separated by a translocation or inversion will no longer
be linked (Figure 1A–C).
We identiﬁed a copy-number loss that could be a small
interstitial deletion, in the T-47D breast cancer cell line.
This was an incidental ﬁnding during exploratory HAPPY
mapping of the inversion described below (Figure 4) at
low resolution, with DNA fragments of up to 500kb
and markers designed at 40-kb spacing. Additional
markers were added, and mapping repeated.
Three consecutive PCR markers on chromosome 8, at
36.528–36.556Mb (all genomic positions are on the refer-
ence genome NCBI Build 36.1, Hg18), gave a copy
number half that of the ﬂanking markers, at 36.504 and
36.593Mb, corresponding to a fall in copy number from 4
to 2 [T-47D is pseudo-tetraploid (16)] (Figure 3).
Figure 3A shows part of the raw HAPPY mapping
data, the ﬁrst 20 of 88 diluted samples. The three
markers within the deletion (grey shading in Figure 3A)
were positive in roughly half as many diluted samples as
the ﬂanking markers. Linkage along the chromosome was
reﬂected in the agreement between the scores for neigh-
bouring markers, i.e. where a marker was positive in a
diluted sample, the ﬂanking markers were usually also
positive. This represents the presence of one or more
DNA molecules that span those markers.
Evidence that this was indeed a simple deletion came
from the markers that ﬂanked the deletion: where a
sample showed absence of the deleted region, the
ﬂanking markers were usually in agreement, i.e. positive
on both sides or negative on both sides. The deleted region
was absent in 42 of 88 samples, and in 37 of these 42 the
ﬂanking markers were in agreement. (A few results will
differ, either because a break in the diluted DNA
happens at random to fall between the two markers or
because of PCR errors.) This suggested that the ﬂanking
pieces of DNA were indeed joined to each other.
The best way to express the results is in terms of linkage,
or, more precisely, the probability that two markers are
physically linked. This is calculated from the agreement
between markers using approaches developed for genetic
mapping. Linkage is expressed as log10 of odds (LOD
score), so for example, a LOD score of 7 means that the
observed results are 10
7 times more likely to have arisen if
the markers are linked than if they are not linked. The
probabilities of linkage are shown in Figure 3B, for all
possible combinations of markers, represented as loops
A
chr 14
chr 8
C Copy number
B Trans
Figure 4. Complex translocation of chromosomes 8 and 14 in T-47D
with inversion and losses of chromosome 8. This was characterized
previously, by ﬂuorescence in situ hybridization (FISH) and cloning
of junction sequences (13). (A) Normal chromosomes 14 (long arm
only) and 8 (short arm only). Dotted lines, breakpoints of transloca-
tion; small circles, key points on the chromosomes; large circles, centro-
meres. (B) Rearranged chromosome. The distal part of 14 has been
translocated to 8, but, in addition, 3.5Mb of chromosome 8 adjacent
to the translocation has been inverted, and about 100kb has been lost
at the inversion junction (indicated by the gap and open arrowhead).
The black arrowhead marks the further copy-number loss at 36.5Mb,
investigated in Figure 3A, which may be on this chromosome or on the
normal chromosome 8. (C) Resulting copy-number proﬁle, showing the
two copy-number losses. There are two copies of the 8;14 translocation,
two normal chromosome 8s and two normal 14s, per cell, as T-47D is
pseudo-tetraploid (13,16). [Adapted from ref. (13)].
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strength of linkage. Strong linkage was seen across the
deletion, with LOD scores >7.
More precisely, the linkage shows that the breakpoints
of the deletion have a high probability of being close to
each other. HAPPY mapping cannot exclude that the re-
arrangement is more complex than a simple deletion, e.g.
that there is DNA inserted in between the breakpoints.
A copy-number loss that was not a simple interstitial
deletion
A contrasting example was also analysed, where a copy-
number loss was not a simple interstitial deletion, but rep-
resented loss of sequence at an inversion junction. In
T-47D there is copy-number loss at an inversion junction,
extending over about 110kb, at 38.1Mb on chromosome
8 (13) (open arrowhead in Figure 4). Figure 3C shows
HAPPY mapping linkage at this copy-number loss.
There is no linkage above the threshold set (LOD > 5)
across the junction, whereas there is clear linkage among
markers on each side of the region of loss, extending over
more than 100kb. (There remains some linkage across the
copy-number loss, because half the copies of chromosome
8 are normal and not affected by the inversion. The
strongest LOD across the loss was 3.2, average 1.5.
Similarly, there is some linkage between markers in the
region of loss and ﬂanking markers, average 1.6, range
0.2–5.05, but it is relatively low because LOD score
measures overall concordance and the rearranged copies
contribute discordant marker results.)
The inversion also creates a new junction between 38.1
and 34.5Mb, and this was detected as new linkage
(Supplementary Figure S1).
Detection of new linkage at a translocation junction
To show that HAPPY mapping would detect linkage
between the newly juxtaposed sequences at the break-
points of a chromosome translocation, we mapped a
translocation junction in the HCC1187 breast cancer cell
line that we had previously cloned and sequenced (17)
(Figure 5A).
HAPPY mapping was applied to detect the new junction
created by the translocation, using PCR markers spaced at
approximately at 7kb intervals around the breakpoints
marked A and C in Figure 5. It showed linkage across
the new junction, e.g. between marker 1a06 on chromo-
some 1 and marker 2a11 on chromosome 8 (Figure 5B).
There was also a loss of linkage between markers
separated by the translocation: e.g. on chromosome 8
the loss of linkage was between markers 2a11 and 1g06
(Figure 5B).
Copy-number counting also supported our previous
ﬁndings (17) that the rearrangement is unbalanced for
chromosome 1, with a change in copy number from 4 to
2 copies at the break, while the rearrangement is balanced
for chromosome 8, with 3 copies throughout the marker
set (Figure 5B). The 4 to 2 step could have been used on its
own to map the breakpoint on chromosome 1 (12), while,
as expected, the copy numbers on chromosome 8 were
essentially constant at an intermediate level.
This application showed that we could detect gain of
linkage between normally distant regions of the genome,
despite a background of other, unrearranged copies. In
addition, it conﬁrmed that there were no additional re-
arrangements at this junction, such as ﬂanking inversions
or deletions.
Assembling new junctions into a genome map
As explained in Figure 1, and illustrated in Figure 6, when
rearrangements are discovered by sequencing of genome
fragments, particularly using the ‘paired end read’ strategy
(2,5,6), junctions between distant parts of the normal
genome are found, but assembling these new junctions
into a map of the genome may not be possible without
additional information. One simple example of this is
where two new junctions could be either close together
on the same rearranged chromosome or on two complete-
ly different chromosomes.
Constructing a correct map requires long-range infor-
mation, such as HAPPY mapping can provide. HAPPY
mapping could exploit junction-speciﬁc PCR markers,
that is, primer sets that span a newly discovered
junction. Furthermore, the linkage should then be
clearer than for markers that are also detecting
unrearranged copies.
To illustrate this consider Figure 6, which shows a
typical example of this problem. Three rearrangement
junctions that might be linked, J1–J3, have been found
in the HCC1187 cell line, either by paired end read
sequencing (18) or by array painting (Figure 6A) (17,19).
There are four ways these junctions could be assembled
into a map (Figure 6B). Two junctions, J1 and J2, map
about 1.4kb apart on chromosome 11, and could reﬂect a
1.4-kb fragment of chromosome 11 inserted into an 11;16
translocation junction (Figure 6B, cases i or iv). Such frag-
ments have been named ‘genomic shards’ (20). However,
the junctions could equally well be on separate rearranged
chromosomes (Figure 6B, cases ii or iii). Similarly, junc-
tions J2 and J3 either could be at opposite ends of a 55-kb
insert of chromosome 16 into chromosome 11 (Figure 6B,
iii or iv) or could be on two different chromosomes, the
products of an approximately-reciprocal translocation
(Figure 6B, i or ii).
We applied HAPPY mapping to map these junctions,
designing junction-speciﬁc primer sets by placing primers
on opposite sides of the junctions. To decide whether J2
and J3 are on the same chromosome, 55kb apart, or on
separate chromosomes and hence unlinked, we needed to
determine the expected linkage over 50–60kb, on a control
region. This control region needed to be at the same copy
number in HCC1187 as the junctions, i.e. one copy. A
single-copy region on chromosome 13 was chosen (17),
and primers designed over an interval of 90kb. For sim-
plicity, we used DNA diluted from stored agarose strings;
as quite a lot of DNA fragments in such material would be
<50kb long (Figure 6C), we improved statistical robust-
ness of the mapping by doubling the sample number to
2 88 samples.
Figure 6 shows the various possible arrangements of the
junctions, and the control measurements of linkage versus
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very high linkage, equivalent to an adjacent position in the
genome. J2 and J3, however, were unlinked, whereas at
55-kb separation they would have been expected to show
an LOD score of around 3.5 (range 1.9–7 for 17 control
primer pairs). Thus, in a quite simple experiment, we have
strong evidence that the junctions are arranged as in
Figure 6B(i): J1 and J2 ﬂank a ‘genomic shard’ inserted
into a 11;16 translocation junction; while J2 and J3,
counter-intuitively, do not represent ﬂanking junctions
of an insert, but are on the two separate products of a
near-reciprocal translocation. Both these results are in
agreement with our molecular cytogenetic analysis of
this cell line: speciﬁcally, we have previously obtained a
PCR product that spans the J1–J2 combined junction, and
have shown that J2 and J3 are on separate products of an
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Figure 5. Detection of changed linkage at a chromosome translocation. (A) Schematic of translocation between chromosome 1 and 8, previously
mapped using array painting (17), in breast cancer cell line HCC1187. On the left, normal chromosomes 1 and 8 with points of breakage A, B and C
(dashed horizontal lines). Right, resulting products and piece of chromosome 1 that is lost. Dotted vertical lines show (not to scale) markers used for
mapping. There are two copies per cell of both translocated chromosomes, and additional untranslocated copies of the breakpoint regions. In
consequence, there are three copies throughout the chromosome 8 region, but a transition from four to two copies at the chromosome 1 breakpoint.
(B) HAPPY mapping around the breakpoints. The heavy horizontal lines represent the reference genome to scale; markers are named below. The
arcs indicate linkage between markers as LOD scores as before; linkages between markers normally on the same chromosome are above the line;
linkages between markers on different chromosomes are below. LOD values >2 are shown. The arrows indicate the largest losses of linkage
compared to that expected for the normal genome, which are likely to indicate the breakpoints. Copy-number results are shown below the
marker names as vertical lines indicating relative copy number, expressed as mean number of copies per sample of the mapping panel; the horizontal
lines joining these show the average values across the markers they cover.
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(continued)
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genetic approaches used were, however, much more la-
borious than the HAPPY mapping approach and not
suited to scaling up.
Detection and mapping of a previously uncloned reciprocal
translocation junction
To apply HAPPY mapping to an unknown rearrange-
ment, we analysed what appeared to be a reciprocal trans-
location between chromosomes 10 and 20, a
t(10;20)(q21;q13.2) (Figure 7A), in the cell line T-47D,
aiming not only to map the translocation to the point of
cloning, but also to determine whether the breakpoints
were joined to each other in the expected way, or
whether there were additional ﬂanking rearrangements.
HAPPY mapping was applied across the breakpoints,
which we had previously mapped to about 100-kb reso-
lution (Supplementary Figure S2). Initially, markers were
spaced roughly every 5kb, then mapping was repeated
with additional markers added around the breakpoints.
Clear new linkage appeared between markers on the
two chromosomes, across both translocation junctions,
and linkage extended as expected to ﬂanking markers
away from the breaks (Figure 7; Supplementary Figure
S3 and Supplementary Table 2). There was also the
expected reduction in linkage between the markers on
each chromosome that were split by the translocation.
The breakpoints could be identiﬁed either from the new
linkage or from the loss of linkage. The linkage also
showed that there were no major additional rearrange-
ments, and that the translocation was almost exactly
reciprocal.
The breakpoints on chromosome 10 were deduced to
be between markers v4-a10 (forward external primer at
57445590bp NCBI Build 36.1) and v4-a12 (at
57446736bp). On chromosome 20, breaks were between
markers v3-b02 (at 54177356bp), joined to v4-a12, and
v4-b06 (at 54179191bp), joined to v4-a10. Marker
v3-b01, at the junction on chromosome 20, was at about
half the copy number of its neighbours: a likely explan-
ation was that it was absent from both products of the
translocation.
The junctions were cloned by PCR between primers
from these marker sets (Supplementary Data). The trans-
location was exactly reciprocal: the junction on both
chromosomes was at chr20: 54178034 or 1bp later, and
chr10: 57446414. The absence of the v3-b01 marker from
the translocation products was explained, as the primers
span the breakpoint on chromosome 20.
DISCUSSION
HAPPY mapping as a tool to map genome
rearrangements
In order to understand a genomic rearrangement it is gen-
erally necessary to construct a map of it. Recent new
technologies, such as high-resolution array-CGH and
massively parallel sequencing, have improved our ability
to detect rearrangements, but they do not provide maps.
In particular, high-throughput sequencing, which can
detect rearrangements by ﬁnding sequences that span re-
arrangement junctions (2,4–6), does not solve this
problem, because sequences can only be assembled unam-
biguously into longer runs if there is a unique genome
order. If some copies of the genome are rearranged
while others are intact, or rearranged differently, as usually
occurs in human disease, there may be more than one way
to assemble junctions into a complete picture that will
show how genes are affected. Figures 1D–G and 6 show
examples of such ambiguity, and similar situations are not
uncommon in constitutional (1) or cancer (19,20,21)
rearrangements.
HAPPY mapping is able to map rearrangements by
measuring linkage. We showed, for example, that it was
able to distinguish between two situations that result in
local copy number loss: a simple interstitial deletion and
loss of material at an inversion junction (Figures 1 and 3).
It was also able to detect change in linkage resulting from
translocation and inversion, and we were able to exploit
this to clone the breakpoints of a reciprocal translocation
in T-47D.
One particular strength of HAPPY mapping is its
ability to detect linkage over distances >10kb. This is
particularly relevant to assembling rearrangement junc-
tions into maps, as we illustrated in Figure 6. HAPPY
mapping should also be able to reach across complex
local rearrangements which quite commonly occur at the
junctions of large-scale rearrangements, such as fragments
of DNA copied from elsewhere the genome and inserted
into the junction of a deletion or tandem repeat, so-called
‘genomic shards’ (1,20,21). It would also permit mapping
of breakpoint junctions at repeat sequences, which tend to
be invisible to sequencing-based strategies. For example,
the chromosome 10 breakpoint in the reciprocal transloca-
tion we mapped is in the middle of an L1 repeat.
Strengths and limitations of the technology
The use of HAPPY mapping to map rearrangements has
several strengths. Firstly, resolution can be freely adjusted
from >200kb down to below 1kb by appropriate choice
Figure 6. Continued
the break towards the q telomere is joined at J3 to a piece of chr. 16 extending from a break at 66.14Mb towards the q telomere; while on a separate
chromosome, chr.11 up to a break at 9.1Mb is joined to the 1.4-kb fragment of chr. 11 between J1 and J2 (10.5195–10.5209Mb), and then joined to
a piece of chr. 16 extending up to the breakpoint at 66.19Mb. (C) Relationship between linkage and genomic distance, established for markers on a
control region of the genome. Note that at around 50–60kb separation, LOD scores between 1.9 and 7 were obtained between various combinations
of control markers. (D) LOD scores obtained between the junction-speciﬁc markers. Linkage between J1 and J2 had a LOD of 31, i.e. these junctions
are very close, whereas no signiﬁcant linkage was found between J2 and J3, which should have shown a LOD score between 1.9 and 7 if they were
55kb apart on the same chromosome. These scores support the arrangement shown in B(i), as expected.
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rounds of mapping can home in on rearrangements to
higher and higher resolution, as in our last example.
Both marker spacing and DNA fragment size can be
adjusted. To show linkage between the chosen markers,
the DNA has to be of sufﬁciently high molecular weight to
span several markers. The upper limit of resolution is set
by the size of DNA fragments that can be selected and
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Figure 7. Mapping a reciprocal chromosome translocation t(10;20)(q21;q13.2) in the T-47D cell line. (A) Diagram of translocation. (B) HAPPY
mapping shows linkage of markers on chromosome 10 (left side of diagram) to markers on chromosome 20 (right side), and loss of linkage across the
breakpoints on each chromosome (dotted red lines). As in Figure 5, the heavy blue horizontal lines represent the reference genome to scale; the arcs
indicate linkage between markers as LOD scores as before; linkages between markers normally on the same chromosome are below the line; linkages
between markers on different chromosomes are above. Linkage arcs in green join the two parts of the derivative 10 chromosome,
der(10)t(10;20)(q21;q13.2) (i.e. the product chromosome with the chromosome 10 centromere); linkage arcs in red join the parts of the reciprocal
product der(20)t(10;20)(q21;q13.2). LOD values >2 are shown. Marker names include their chromosome and position of Fex primer in bp. Above
the marker names are vertical lines indicating relative copy number. Insets (C) and (D): the breakpoint regions with genomic scale stretched 6-fold.
Data shown was from a ﬁnal mapping run in which all markers were used together, for illustration purposes.
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around 1Mb can be prepared by pulsed-ﬁeld electrophor-
esis, taking samples that contain a fraction of a genome
directly from the gel. These are best combined with
markers spaced not more than 200kb apart (10). In the
mapping experiments presented here, the more convenient
approach of diluting DNA from melted agarose was gen-
erally used, giving quite large DNA fragments, up to
hundreds of kilobases, depending on how fresh the
DNA preparation is. These show up large-scale changes
in linkage, with neighbouring markers conﬁrming each
other. The only limitation of such large fragments is that
the relative order of markers is less clearly distinguished,
and, therefore, local rearrangements, such as small inver-
sions, would be overlooked or poorly resolved. To analyse
such local rearrangements, smaller DNA fragments
should be used.
Secondly, the method is technologically simple and can
be implemented without elaborate equipment. On the
scale demonstrated here, the PCRs would be manageable
with multi-channel pipettes. Equally, if the PCRs are set
up with a robot there is very little hands-on time, and the
technique can be scaled up.
Thirdly, only very small amounts of DNA are required.
Each sample requires  0.7 haploid genomes (2.3pg).
Therefore, an experiment with 100 samples would
require 0.23ng DNA, the equivalent of 35 diploid cells
or fewer polyploid cancer cells (22).
Among potential limitations, the sensitivity of HAPPY
mapping to analyse a rearrangement can be limited by the
presence of normal (or differently rearranged) DNA. This
should not be an issue for germ-line rearrangements,
where equal amounts of rearranged and normal genome
are present. In most of our experiments, there was an
equal amount of normal and rearranged DNA, and
linkage changes were clear. In cancers, however, there
may be two or more other copies of the cancer genome
or DNA from contaminating non-cancer cells. Where
rearranged copies are less than half the total, linkage
probability can be maximized by increasing the number
of dilution samples scored, as in Figure 6, and by ensuring
that the DNA fragments are long enough to give strong
linkage over the distances involved.
This problem can however be eliminated where it is
possible to use junction-speciﬁc markers, as in Figure 6,
which completely ignore normal DNA. This will be the fa-
voured approach if sequencing and paired-end sequencing
become the dominant way to discover rearrangements.
Junctions will be discovered, and junction-speciﬁc
markers will then permit assembly of the discovered junc-
tions into a map, as in Figure 6.
A further limitation is the cost of deploying PCR-based
HAPPY mapping on a large scale, such as the whole
genome, which is discussed below.
In the context of tumour biopsies, as opposed to cell
lines or germ-line rearrangements, an important strength
is that the technology only requires DNA, and only in
small amounts. This is in contrast to cytogenetic methods,
which require chromosome spreads and therefore dividing
cells, and so are often restricted to cell lines (2). HAPPY
mapping does require intact DNA, so cannot be applied,
over any substantial distance, to DNA derived from
formalin-ﬁxed parafﬁn-embedded material, because such
DNA is usually fragmented to <1kb, but high-quality
DNA is often available from snap-frozen tumour
material, and should usually be available from patients
with germ-line rearrangements.
An issue with tumour biopsies, other than leukaemia
samples, will be contaminating normal DNA from non-
cancer cells. There are two solutions: use of junction-
speciﬁc markers as just discussed, and microdissection.
Since very little DNA is required, enriching for tumour
cells by microdissection is entirely feasible, and can
achieve almost 100% tumour cells for many epithelial
malignancies (22).
The place of HAPPY mapping in studying rearranged
genomes
The tools available for interrogating genome structure can
usefully be divided into those that permit genome-wide
scans (e.g. cytogenetics, array–CGH, paired-end
sequencing) and those that are targeted at speciﬁc
genomic loci (e.g. FISH). HAPPY mapping, as described
here, using PCR, belongs in the second group: it is most
suited to detailed analysis of individual rearrangements
that have already been discovered by genome-wide
technologies.
HAPPY mapping offers the ability to determine the
physical relationship between segments of rearranged
DNA, on a scale from <1kb up to about 1Mb, using
small amounts of input DNA. It provides information
somewhat analogous to FISH, except that it operates up
to 1Mb, while FISH can map rearrangements in the range
100kb to 1Mb on interphase nuclei, and larger than
several megabases on metaphase chromosome spreads
(e.g. 13). As discussed above, HAPPY mapping comple-
ments array CGH and paired-end sequencing (Figure 1).
Array-CGH detects breakpoints but cannot tell which
breakpoints are joined to which. It also fails to detect
balanced rearrangements, including inversions and recip-
rocal translocations. Resolution is often still limiting:
current genome-wide arrays on a single slide, such as the
Affymetrix SNP6 array, will often not map breakpoints
well enough for immediate cloning by PCR, and can
barely detect single-copy duplications of less than
around 100kb (e.g. 19). Paired-end massively parallel
sequencing [including variations often called mate-pair
sequencing, in which both ends of circularized DNA frag-
ments of 2–5kb are sequenced (5)], can identify rearrange-
ment junctions (e.g. 18), but cannot tell how they assemble
into a larger-scale map, e.g. whether two junctions are on
the same chromosome or not (Figures 1 and 6). HAPPY
mapping can provide this information, provided the junc-
tions are within about 1Mb of each other, which will
normally be a large enough scale to determine how
genes are affected by the rearrangement, e.g. whether
two junctions represent opposite ends of a small insertion
(Figure 6). Paired-end sequencing has been used to provide
longer-range mapping, by end-sequencing fosmid or BAC
libraries made from a rearranged genome, e.g. to study
structural aberrations and identify haplotypes in human
PAGE 11 OF 13 Nucleic Acids Research,2011, Vol.39, No. 13 e85genomes (4,23), but library construction is demanding.
For tumour samples, a further major limitation of
current paired-end protocols, particularly mate-pair and
library construction, is the need for several micrograms of
input DNA to permit fragment size selection (24,25).
Could HAPPY mapping be used to scan the whole
genome for rearrangements? Scaling up to genome-wide
scans by PCR is probably impractical, because of the
numbers of primers and PCR reactions involved—e.g. a
scan for rearrangements >30kb would need 100000
markers at 30-kb intervals and 10
7 PCR reactions. The
statistical signiﬁcance of linkage changes would also be
weakened by the many samples.
However, in future, it should be possible to implement
HAPPY mapping using massively parallel sequencing
instead of PCR markers, and this may permit
genome-wide discovery and assembly of rearrangements.
Instead of using PCR to score each diluted sample of a
HAPPY panel for the presence or absence of chosen
marker sequences, this can be done by global ampliﬁca-
tion of each diluted sample, followed by massively parallel
sequencing. Exhaustive sequencing is not necessary (and,
given the imperfections of global ampliﬁcation, is not
possible): the genome can be divided into segments of,
for example, 5kb, and the presence of only a few
sequence reads from a given segment is then enough to
conﬁrm that segment’s presence in a given dilution
sample. In this way, relatively light sequencing of each
dilution sample is enough to ‘type’ it for several hundred
thousand ‘markers’ (DNA segments) throughout the
genome. The cost of sequencing can be minimized by
sequencing many dilution samples together, using
bar-coding to distinguish the samples [i.e. adding a
sample-speciﬁc linker sequence to all the DNA fragments
in a given sample (26)].
This method of using sequencing instead of PCR
markers has already been applied in the de novo
mapping of the normal genome of Hydra ( 1.3Gb,
two-thirds the size of the human genome), and worked
well (Rokhsar,D., Chapman,J., David,C., Steele,R. and
Dear,P.H., unpublished data).
This approach should enable genome-wide detection of
complex rearrangements at a reasonable cost. Indeed,
where second-generation sequencing is already envisaged
for identifying junctions, copy-number changes or muta-
tions, this type of mapping could be performed at little
additional cost, simply by starting with a panel of suitable
HAPPY dilution samples instead of a single large DNA
sample.
CONCLUSION
HAPPY-mapping has previously been used in the
assembly of whole genomes (15,27–29). In this paper, we
have demonstrated its utility for identifying the physical
relationship between segments of DNA in a rearranged
cancer genome. HAPPY-mapping delivers high-resolution
mapping information over a range of distances (1–200kb)
that can easily be controlled through marker design and
fragment size selection. It will therefore be a useful
complementary technique to genome-wide techniques,
such as array-CGH and paired end sequencing, which
discover rearrangements but do not provide long-range
mapping information. In addition, DNA requirements
are minimal and the equipment needed is available in
most molecular biology laboratories.
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